ROBERT S. GOLDMAN
ROBERT S. GOLDMAN publishes mostly in Psychiatry and Mental health, Cognitive Neuroscience and Clinical Psychology, on topics such as Schizophrenia research and treatment, Attention Deficit Hyperactivity Disorder and Bipolar Disorder and Treatment.
- World rank
- #846,854 of 7,710,434 ranked researchers
- Rank in United States
- #280,990 of 1,627,098
- Works
- 133
- Citations
- 7.1k
- Citations per work
- 53.1
What does ROBERT S. GOLDMAN research?
ROBERT S. GOLDMAN's work is mostly in Medicine (49%), Psychology (13%), Neuroscience (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences6649.3%
- Medicine6649.3%
- Everything else3627.0%
- Social Sciences1813.4%
- Psychology1813.4%
- Life Sciences1410.3%
- Neuroscience1410.3%
- 1Psychiatry and Mental health42% of their works
- 2Cognitive Neuroscience10% of their works
- 3Clinical Psychology10% of their works
- 4Pediatrics, Perinatology and Child Health4% of their works
- 5Experimental and Cognitive Psychology4% of their works
- 6Pharmacology3% of their works
Research topics
- Schizophrenia research and treatment
- Attention Deficit Hyperactivity Disorder
- Bipolar Disorder and Treatment
- Child and Adolescent Psychosocial and Emotional Development
- Functional Brain Connectivity Studies
- Pharmaceutical studies and practices
- Dementia and Cognitive Impairment Research
- Treatment of Major Depression
Which keywords describe ROBERT S. GOLDMAN's research?
The keywords of their largest research topics: Neurobiology, Prevalence, Antipsychotic Drugs, Neurocognitive Deficits, Neuroimaging, ADHD, Attention-Deficit/Hyperactivity Disorder and Bipolar Spectrum Disorder.
- Ketamine
- Resting-State fMRI
- Off-Label Drug Use
- Functional Connectivity
- Psychopathology
- Depression
- Bipolar Spectrum Disorder
- ADHD
- Neurocognitive Deficits
- Prevalence
- Neurobiology
- Antipsychotic Drugs
- Neuroimaging
- Attention-Deficit/Hyperactivity Disorder
- Treatment Guidelines
- Emotion Regulation
- Alzheimer's Disease
- Mild Cognitive Impairment
- Pediatric Pharmacokinetics
- Antidepressant
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Neurobiology612 topics
- Prevalence612 topics
- Antipsychotic Drugs541 topic
- Neurocognitive Deficits541 topic
- Neuroimaging402 topics
- ADHD331 topic
- Attention-Deficit/Hyperactivity Disorder331 topic
- Bipolar Spectrum Disorder281 topic
- Treatment Guidelines281 topic
- Depression242 topics
- Emotion Regulation141 topic
- Psychopathology141 topic
- Alzheimer's Disease121 topic
- Functional Connectivity121 topic
- Mild Cognitive Impairment121 topic
- Off-Label Drug Use121 topic
- Pediatric Pharmacokinetics121 topic
- Resting-State fMRI121 topic
- Antidepressant101 topic
- Ketamine101 topic
Where does ROBERT S. GOLDMAN work?
ROBERT S. GOLDMAN's main affiliation in the publication record is Vion Pharmaceuticals (United States), United States.
How many publications and citations does ROBERT S. GOLDMAN have?
OpenAlex counts 133 works and 7,064 citations for ROBERT S. GOLDMAN, an h-index of 39, ranking #846,854 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about ROBERT S. GOLDMAN. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.